1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 5
FEATURED COMPANIES
- Granules India Ltd.
- Mallinckrodt Plc
- Meghmani Group
- SEQENS GROUP
- MORE
Global Paracetamol Market 2020-2024
The paracetamol market is poised to grow by $ 484.77 mn during 2020-2024 progressing at a CAGR of 8% during the forecast period. The reports on paracetamol market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the significant use of paracetamol as an API in large number of OTC drugs, wide application of paracetamol as a first line-therapy for symptomatic relief and growing use of paracetamol as an antipyretic in COVID-19 pandemic. In addition, significant use of paracetamol as an API in large number of OTC drugs is anticipated to boost the growth of the market as well.
The paracetamol market analysis includes type segment and geographic landscapes.
The paracetamol market is segmented as below:
By Type
The paracetamol market covers the following areas:
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
This study presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
The market research report provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
The paracetamol market is poised to grow by $ 484.77 mn during 2020-2024 progressing at a CAGR of 8% during the forecast period. The reports on paracetamol market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the significant use of paracetamol as an API in large number of OTC drugs, wide application of paracetamol as a first line-therapy for symptomatic relief and growing use of paracetamol as an antipyretic in COVID-19 pandemic. In addition, significant use of paracetamol as an API in large number of OTC drugs is anticipated to boost the growth of the market as well.
The paracetamol market analysis includes type segment and geographic landscapes.
The paracetamol market is segmented as below:
By Type
- Powder
- Granules
- North America
- Europe
- Asia
- ROW
The paracetamol market covers the following areas:
- Paracetamol market sizing
- Paracetamol market forecast
- Paracetamol market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
This study presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
The market research report provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5
FEATURED COMPANIES
- Granules India Ltd.
- Mallinckrodt Plc
- Meghmani Group
- SEQENS GROUP
- MORE
Executive Summary
Geographic Landscape
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Type - Market share 2019-2024 (%)
22: Comparison by Type
23: Powder - Market size and forecast 2019-2024 ($ million)
24: Powder - Year-over-year growth 2019-2024 (%)
25: Granules - Market size and forecast 2019-2024 ($ million)
26: Granules - Year-over-year growth 2019-2024 (%)
27: Market opportunity by Type
28: Customer landscape
29: Market share by geography 2019-2024 (%)
30: Geographic comparison
31: North America - Market size and forecast 2019-2024 ($ million)
32: North America - Year-over-year growth 2019-2024 (%)
33: Europe - Market size and forecast 2019-2024 ($ million)
34: Europe - Year-over-year growth 2019-2024 (%)
35: Asia - Market size and forecast 2019-2024 ($ million)
36: Asia - Year-over-year growth 2019-2024 (%)
37: ROW - Market size and forecast 2019-2024 ($ million)
38: ROW - Year-over-year growth 2019-2024 (%)
39: Key leading countries
40: Market opportunity by geography ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Overview
48: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Product and service
49: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Key offerings
50: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Key customers
51: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Segment focus
52: Anqiu Luan Pharmaceutical Co. Ltd. - Overview
53: Anqiu Luan Pharmaceutical Co. Ltd. - Product and service
54: Anqiu Luan Pharmaceutical Co. Ltd. - Key offerings
55: Anqiu Luan Pharmaceutical Co. Ltd. - Key customers
56: Anqiu Luan Pharmaceutical Co. Ltd. - Segment focus
57: ATABAY KIMYA SANAYI TICARET AS - Overview
58: ATABAY KIMYA SANAYI TICARET AS - Product and service
59: ATABAY KIMYA SANAYI TICARET AS - Key offerings
60: ATABAY KIMYA SANAYI TICARET AS - Key customers
61: ATABAY KIMYA SANAYI TICARET AS - Segment focus
62: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Overview
63: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Product and service
64: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Key offerings
65: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Key customers
66: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Segment focus
67: Granules India Ltd. - Overview
68: Granules India Ltd. - Business segments
69: Granules India Ltd. - Key offerings
70: Granules India Ltd. - Key customers
71: Granules India Ltd. - Segment focus
72: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Overview
73: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Product and service
74: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Key offerings
75: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Key customers
76: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Segment focus
77: Mallinckrodt Plc - Overview
78: Mallinckrodt Plc - Business segments
79: Mallinckrodt Plc - Key offerings
80: Mallinckrodt Plc - Key customers
81: Mallinckrodt Plc - Segment focus
82: Meghmani Group - Overview
83: Meghmani Group - Business segments
84: Meghmani Group - Key offerings
85: Meghmani Group - Key customers
86: Meghmani Group - Segment focus
87: SEQENS GROUP - Overview
88: SEQENS GROUP - Business segments
89: SEQENS GROUP - Key offerings
90: SEQENS GROUP - Key customers
91: SEQENS GROUP - Segment focus
92: Zhejiang Kangle Pharmaceutical Co. Ltd. - Overview
93: Zhejiang Kangle Pharmaceutical Co. Ltd. - Product and service
94: Zhejiang Kangle Pharmaceutical Co. Ltd. - Key offerings
95: Zhejiang Kangle Pharmaceutical Co. Ltd. - Key customers
96: Zhejiang Kangle Pharmaceutical Co. Ltd. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations
- Market Overview
- Market ecosystem
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segments
- Comparison by Type
- Powder - Market size and forecast 2019-2024
- Granules - Market size and forecast 2019-2024
- Market opportunity by Type
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Volume driver – Demand led growth
- Market challenges
- Market trends
- Vendor landscape
- Landscape disruption
- Competitive Scenario
- Vendors covered
- Market positioning of vendors
- Anhui BBCA Likang Pharmaceutical Co. Ltd.
- Anqiu Luan Pharmaceutical Co. Ltd.
- ATABAY KIMYA SANAYI TICARET AS
- Farmson Pharmaceutical Gujarat Pvt. Ltd.
- Granules India Ltd.
- Hebei Jiheng (Group) Pharmaceutical Co. Ltd.
- Mallinckrodt Plc
- Meghmani Group
- SEQENS GROUP
- Zhejiang Kangle Pharmaceutical Co. Ltd.
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Type - Market share 2019-2024 (%)
22: Comparison by Type
23: Powder - Market size and forecast 2019-2024 ($ million)
24: Powder - Year-over-year growth 2019-2024 (%)
25: Granules - Market size and forecast 2019-2024 ($ million)
26: Granules - Year-over-year growth 2019-2024 (%)
27: Market opportunity by Type
28: Customer landscape
29: Market share by geography 2019-2024 (%)
30: Geographic comparison
31: North America - Market size and forecast 2019-2024 ($ million)
32: North America - Year-over-year growth 2019-2024 (%)
33: Europe - Market size and forecast 2019-2024 ($ million)
34: Europe - Year-over-year growth 2019-2024 (%)
35: Asia - Market size and forecast 2019-2024 ($ million)
36: Asia - Year-over-year growth 2019-2024 (%)
37: ROW - Market size and forecast 2019-2024 ($ million)
38: ROW - Year-over-year growth 2019-2024 (%)
39: Key leading countries
40: Market opportunity by geography ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Overview
48: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Product and service
49: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Key offerings
50: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Key customers
51: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Segment focus
52: Anqiu Luan Pharmaceutical Co. Ltd. - Overview
53: Anqiu Luan Pharmaceutical Co. Ltd. - Product and service
54: Anqiu Luan Pharmaceutical Co. Ltd. - Key offerings
55: Anqiu Luan Pharmaceutical Co. Ltd. - Key customers
56: Anqiu Luan Pharmaceutical Co. Ltd. - Segment focus
57: ATABAY KIMYA SANAYI TICARET AS - Overview
58: ATABAY KIMYA SANAYI TICARET AS - Product and service
59: ATABAY KIMYA SANAYI TICARET AS - Key offerings
60: ATABAY KIMYA SANAYI TICARET AS - Key customers
61: ATABAY KIMYA SANAYI TICARET AS - Segment focus
62: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Overview
63: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Product and service
64: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Key offerings
65: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Key customers
66: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Segment focus
67: Granules India Ltd. - Overview
68: Granules India Ltd. - Business segments
69: Granules India Ltd. - Key offerings
70: Granules India Ltd. - Key customers
71: Granules India Ltd. - Segment focus
72: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Overview
73: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Product and service
74: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Key offerings
75: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Key customers
76: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Segment focus
77: Mallinckrodt Plc - Overview
78: Mallinckrodt Plc - Business segments
79: Mallinckrodt Plc - Key offerings
80: Mallinckrodt Plc - Key customers
81: Mallinckrodt Plc - Segment focus
82: Meghmani Group - Overview
83: Meghmani Group - Business segments
84: Meghmani Group - Key offerings
85: Meghmani Group - Key customers
86: Meghmani Group - Segment focus
87: SEQENS GROUP - Overview
88: SEQENS GROUP - Business segments
89: SEQENS GROUP - Key offerings
90: SEQENS GROUP - Key customers
91: SEQENS GROUP - Segment focus
92: Zhejiang Kangle Pharmaceutical Co. Ltd. - Overview
93: Zhejiang Kangle Pharmaceutical Co. Ltd. - Product and service
94: Zhejiang Kangle Pharmaceutical Co. Ltd. - Key offerings
95: Zhejiang Kangle Pharmaceutical Co. Ltd. - Key customers
96: Zhejiang Kangle Pharmaceutical Co. Ltd. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations
Note: Product cover images may vary from those shown
3 of 5
FEATURED COMPANIES
- Granules India Ltd.
- Mallinckrodt Plc
- Meghmani Group
- SEQENS GROUP
- MORE
The publisher recognizes the following companies as the key players in the global paracetamol market: Anhui BBCA Likang Pharmaceutical Co. Ltd., Anqiu Luan Pharmaceutical Co. Ltd., ATABAY KIMYA SANAYI TICARET AS, Farmson Pharmaceutical Gujarat Pvt. Ltd., Granules India Ltd., Hebei Jiheng (Group) Pharmaceutical Co. Ltd., Mallinckrodt Plc, Meghmani Group, SEQENS GROUP, and Zhejiang Kangle Pharmaceutical Co. Ltd.
Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing number of approvals for paracetamol-based combinations."
According to the report, one of the major drivers for this market is the significant use of paracetamol as an API in large number of OTC drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing number of approvals for paracetamol-based combinations."
According to the report, one of the major drivers for this market is the significant use of paracetamol as an API in large number of OTC drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
- Anhui BBCA Likang Pharmaceutical Co. Ltd.
- Anqiu Luan Pharmaceutical Co. Ltd.
- ATABAY KIMYA SANAYI TICARET AS
- Farmson Pharmaceutical Gujarat Pvt. Ltd.
- Granules India Ltd.
- Hebei Jiheng (Group) Pharmaceutical Co. Ltd.
- Mallinckrodt Plc
- Meghmani Group
- SEQENS GROUP
- Zhejiang Kangle Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown
5 of 5
LOADING...
